Victory Munder Mid-Cap Core Growth Fund HALO Holdings History
Victory Munder Mid-Cap Core Growth Fund's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, VICTORY PORTFOLIOS held 73,800.00 shares of Halozyme Therapeutics Inc(HALO), totaling $4.71 Mil. This investment constitutes 1.81% of their stock portfolio, and VICTORY PORTFOLIOS now holds 0.06% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q2. And since then Victory Munder Mid-Cap Core Growth Fund has made 5 purchases of HALO, at an average price of $45.38, for a total of 168,700.00 shares. In addition, there have been 7 sales at an average price of $46.77 for 94,900.00 shares. Based on historical transaction data and HALO's current price of $56.45, Victory Munder Mid-Cap Core Growth Fund's estimated gain on his HALO holdings is $947,808.00, reflecting a 12.38% gain to date.
Victory Munder Mid-Cap Core Growth Fund HALO ($56.45) Holding Chart
Victory Munder Mid-Cap Core Growth Fund HALO ($56.45) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
